Your session is about to expire
← Back to Search
Diagnostic Test
SARS-CoV-2 OTC At Home Test
N/A
Waitlist Available
Research Sponsored by 3EO Health
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1-16 weeks
Awards & highlights
No Placebo-Only Group
Summary
This trial is testing a new rapid COVID-19 detection method called the 3EO Health COVID-19 Test. It targets people at medical facilities to see how well it works. The test uses a nasal swab and a special device to quickly find the virus's genetic material.
Eligible Conditions
- Coronavirus Pandemic
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 1-16 weeks
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1-16 weeks
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Correlation of the 3EO Health SARS-CoV-2 standard of care (PCR) Zymo rRT-PCR results of the anterior nare sample.
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: Study GroupsExperimental Treatment1 Intervention
Positives: Symptomatic vs. Asymptomatic Negatives: Symptomatic vs. Asymptomatic
Each broken down by age groups:
2-14 years old 15-24 years old 25-64 years old 65+ years old
Find a Location
Who is running the clinical trial?
3EO HealthLead Sponsor
1 Previous Clinical Trials
202 Total Patients Enrolled
Jerika AcostaStudy DirectorMedicept Inc
1 Previous Clinical Trials
202 Total Patients Enrolled